Catabasis Pharmaceuticals, Inc. Management To Present At October Investor Conferences
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will present new data from its antibiotics portfolio at IDWeek 2014, October 8-12, in Philadelphia, PA. Presentations of these data are important as new antibiotics are needed for the growing global public health issue of serious and sometimes life-threatening infections.
Catabasis Pharmaceuticals, Inc., a clinical stage drug development company built on a pathway pharmacology technology platform, today announced that management will present an overview of Catabasis and its lead drug development programs at the following investor conferences in October:
•Leerink Partners Rare Diseases Roundtable on October 1, 2014, at Le Parker Meridien Hotel in New York. The Catabasis presentation will take place at 2:20pm ET.
Help employers find you! Check out all the jobs and post your resume.
Catabasis Pharmaceuticals, Inc., a clinical stage drug development company built on a pathway pharmacology technology platform, today announced that management will present an overview of Catabasis and its lead drug development programs at the following investor conferences in October:
•Leerink Partners Rare Diseases Roundtable on October 1, 2014, at Le Parker Meridien Hotel in New York. The Catabasis presentation will take place at 2:20pm ET.
Help employers find you! Check out all the jobs and post your resume.